// App-Quantinova.ai

361 : Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Researchers

Presenter

  • Nikhil Patkar

Principal Investigators

  • Chinmayee Kakirde

  • Rakhi Salve

  • Prasanna Bhanshe

  • Gaurav Chatterjee

  • Sweta Rajpal

  • Swapnali Joshi

  • Shruti Chaudhary

  • Rohan Kodgule

  • Dhanlaxmi Lalit Shetty

  • Hasmukh Jain

  • Bhausaheb Bagal

  • Hari Menon

  • Navin Khattry

  • Manju Sengar

  • Prashant Tembhare

  • Papagudi Ganesan Subramanian

  • Sumeet Gujral

Medical Centers

  • Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India

  • Tata Memorial Centre, Mumbai, India

  • Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India

  • CCE-25, Sector 22, Utsav Chowk - CISF Rd, Owe Camp, Kharghar, Maharashtra, Hematopathology Laboratory, TATA Memorial Centre, ACTREC, Navi Mumbai, India

  • Tata Memorial Centre, Kharghar, IND

  • Tata Memorial Centre, Mumbai, Maharashtra, India

  • Hematopathology Laboratory, TATA Memorial Centre, ACTREC, Navi Mumbai, India

  • Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, ACTREC, Navi Mumbai, Maharashtra, IND

  • Department of Pathology, Tata Memorial Centre, Mumbai, India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Department of Medical Oncology, Tata Memorial Centre (TMC), Mumbai, India

  • Homi Bhabha National Institute, Mumbai, India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India

  • Cytecare cancer centre, Medical Oncology, Bengaluru, India

  • BMT unit, Department of Medical oncology, ACTREC., Tata Memorial Centre, Navi Mumbai, India

  • Homi Bhabha National University., Mumbai., India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Adult Hematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India

  • Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India

  • Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Mumbai, Maharashtra, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • DNA methyltransferase 3 alpha

  • Tet methylcytosine dioxygenase 2

  • Hormone receptor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A